Samlyn Capital »

Sage Therapeutics shares owned by Samlyn Capital

Quarter-by-quarter ownership of Sage Therapeutics (SAGE) shares owned by Samlyn Capital from 13F filings

Historical chart of Samlyn Capital investment in Sage Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sage Therapeutics held by Samlyn Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sage Therapeutics by Samlyn Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $17M 769k 21.67
2023-09-30 $15M 740k 20.58
2017-06-30 $3.8M 47k 79.63
2017-03-31 $4.0M 57k 71.07
2016-12-31 $4.2M 82k 51.07